Abiochem Biotechnology Co. key facts
as of Oct 2026- Operator of a bio-intelligent manufacturing company focused on manufacturing chemical and biological products.
- Abiochem Biotechnology Co. is valued at approximately $706.9M as of Oct 2026 (last reported valuation).
- It has raised $215.9M; the latest was Later Stage VC ($62.8M) in Jul 2025.
- Notable investors include Addor Capital, Temasek Holdings, CMB International Capital, Highlight Capital, Zizhu Xiaomiao PE — 13 tracked in total.
- Status: Privately Held (backing).
Abiochem Biotechnology Co.'s last reported valuation, Dec 2022. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch Abiochem Biotechnology Co.: the Monday email on marks, rounds and moves
Abiochem Biotechnology Co. funding rounds
No funding rounds for Abiochem Biotechnology Co. are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Abiochem Biotechnology Co.
13+Abiochem Biotechnology Co. valuation
Abiochem Biotechnology Co.'s last reported valuation was $707 million in Dec 2022. No priced round, secondary trade or fund mark has surfaced since.
Abiochem Biotechnology Co. investors
13 investors are on record for Abiochem Biotechnology Co., including Addor Capital, Temasek Holdings, CMB International Capital and Highlight Capital.
About Abiochem Biotechnology Co.
Operator of a bio-intelligent manufacturing company focused on manufacturing chemical and biological products. The company studies and develops new biocatalysis and synthetic biology processes, providing clients with one-stop customized genetic and enzyme engineering services in pharmaceuticals, agriculture, and food fields.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2015
- Employees
- 346
- Website
- abiochem.cn/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.